Abstract
The CNAO (Italian acronym that stands for National Centre for Oncological Hadrontherapy) has been realised in Pavia, Italy. It is a clinical facility created and financed by the Italian Ministry of Health and conceived to supply hadrontherapy treatments to patients recruited all over the Country. A qualified network of clinical and research institutes, the CNAO Collaboration, has been created to build and to run the centre. This organizational model turned out to be very efficient and fruitful to reach the goal of introducing the most advanced techniques and procedures of hadrontherapy. Three treatment rooms with four beam ports (three horizontal and one vertical) are operational and one experimental room has been built. Beams of protons with kinetic energies up to 250MeV and beams of carbon ions with maximum kinetic energy of 400MeV/u are transported and delivered by active scanning systems. The machine operation started in 2009 with the commissioning of the high-technology components that form the acceleration chain from the sources to the patient. The dosimetry and radiobiology tests have been completed with proton beams and CNAO obtained the authorisation to start treating patients. Statistics from the Italian Association of Radiotherapists and Oncologists (AIRO) have estimated that more than 3% of the overall Italian radiotherapy annual patients, i.e. more than 3000 new patients per year, would preferably be treated with hadrontherapy, but this number is steadily increasing. Pre-selection criteria are defined on the basis of established clinical protocols and the hospitals and the clinics in the network will address to the CNAO those patients that satisfy the criteria. This paper outlines the project development, the technical aspects of the realisation and commissioning and the clinical issues relevant for the patients treatments at CNAO.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
U. Amaldi, G. Tosi, Per un centro di teleterapia con adroni, TERA 91/1 GEN 1 (1991)
U. Amaldi, M. Silari (Editors), The TERA Project and the Centre for Oncological Hadrontherapy, Vol. I and II (INFN-Laboratori Nazionali, Frascati, 1995). The “Blue Book”
U. Amaldi (Editor), The National Centre for Oncological Hadrontherapy at Mirasole (INFN-LNF, Frascati, 1997). The “Red Book”
L. Badano, S. Rossi, Proton-Ion Medical Machine Study (PIMMS), Part I and II, CERN/PS 1999-010 DI and CERN/PS 2000-007 DR, Geneva (2000)
E. Borloni, R. Orecchia, S. Rossi (Editors), Attività propedeutica alla sperimentazione su pazienti, Progetto di Sperimentazione Clinica, Parte I, submitted to the Italian Ministry of Health (2010)
G. Kraft, Prog. Part. Nucl. Phys. 45, 473 (2000)
International Commission on Radiation Units and Measurements, The quality factor in radiation protection, ICRU Report 40 (1986)
K.D. Gross, M. Pavlovic (Editors), Proposal for a dedicated ion beam facility for cancer therapy, GSI (1998)
R. Orecchia et al., Tumori 95, 169 (2009)
S. Rossi, Developments in proton and light ion therapy, EPAC06 (2006) p. 3631
M. Pullia, Status report on the Centro Nazionale di Adroterapia Oncologica (CNAO), EPAC08, TUOCG02 (2008)
E. Bressi, Status report on the Centro Nazionale di Adroterapia Oncologica (CNAO), PAC09, TU6PFP005 (2009)
G. Bazzano, Status of the commissioning of the Centro Nazionale di Adroterapia Oncologica (CNAO), IPAC10, MOPEB005 (2010)
G. Ciavola, Commissioning of the ECR ion source at CNAO, EPAC08, MOPC145 (2008)
B. Schlitt, Linac commissioning at the Italian Hadrontherapy Centre CNAO, IPAC10, MOPEA003 (2010)
C. Priano, Magnetic modeling, Measurements and sorting of the CNAO synchrotron Dipoles and Quadrupoles, IPAC10, MOPEB004 (2010)
L. Badano, S. Rossi, Characteristics of a Betatron Core for Extraction in a Proton-Ion Medical Synchrotron, CERN/PS 97-19 (DI) (1997)
S Giordanengo, The CNAO system to monitor and control hadron beams for therapy, Manuscript IEEE 2008
S. Giordanengo et al., Nucl. Instrum. Methods A 613, 317 (2010)
T. Haberer et al., Nucl. Instrum. Methods Phys. Res. A 330, 296 (1993)
A. Knopf et al., Med. Phys. 37, 4608 (2010)
G. Baroni et al., J. Radiat. Res. A 48, 61 (2007)
A. Esmaili et al., Technol. Cancer Res. Treat. 9, 551 (2010)
G. Balbinot, Beam Diagnostics in the CNAO Injection Line Commissioning, DIPAC09, Basel, Switzerland (2009)
M.T. Gillin et al., Med. Phys. 37, 154 (2010)
International Commission on Radiation Units and Measurements, Prescribing, recording and reporting proton-beam therapy, ICRU Report 78. Journal of the ICRU 7 (2) (2007)
C.P. Karger et al., Phys. Med. Biol. 55, 193 (2010)
U. Schneider et al., Phys. Med. Biol. 41, 111 (2001)
E. Rietzel et al., Radiat. Oncol. 23, 2 (2007)
G.H. Hartmann et al., Phys. Med. Biol. 44, 1193 (1999)
International Atomic Energy Agency, Absorbed Dose Determination in External Beam Radiotherapy, Technical Report Series No. 398, IAEA, Vienna (2000)
O. Jaekel et al., Med. Phys. 31, 1009 (2004)
H.J. Brede et al., Phys. Med. Biol. 51, 3667 (2006)
O. Jaekel et al., Med. Phys. 27, 1588 (2000)
C.P. Karger et al., Med. Phys. 27, 725 (2000)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rossi, S. The status of CNAO. Eur. Phys. J. Plus 126, 78 (2011). https://doi.org/10.1140/epjp/i2011-11078-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1140/epjp/i2011-11078-8